Panotile Cipro (Ciprofloxacin)

Panotile Cipro is a broad‑spectrum fluoroquinolone indicated for infections affecting several organ systems:

• Urinary tract infection: helps eradicate common uropathogens and relieve symptoms.
• Respiratory tract infection: effective against typical bacterial causes of acute bronchitis and community‑acquired pneumonia.
• Skin and soft‑tissue infection: combats Staphylococcus aureus and Streptococcus species in cellulitis and wound infections.

• Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription and repair. By blocking these enzymes, the drug prevents bacterial cell division and leads to rapid bacterial cell death, providing a bactericidal effect against susceptible Gram‑negative and Gram‑positive organisms.

Ciprofloxacin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Nausea: mild stomach upset that often resolves without treatment.
• Diarrhea: loose stools that may occur during therapy.
• Headache: transient head pain reported by some patients.
• Dizziness: occasional light‑headed sensation.
• Rash: mild skin redness or itching.
• Photosensitivity: increased skin sensitivity to sunlight.

Serious or Rare Side Effects

• Tendon rupture: sudden tendon pain or swelling, especially in the Achilles tendon.
• Peripheral neuropathy: tingling, numbness or burning sensations in extremities.
• QT prolongation: irregular heart rhythm detectable on ECG.
• Severe allergic reaction: hives, swelling, or breathing difficulty.
• Clostridioides difficile colitis: persistent watery diarrhea with abdominal pain.
• Hepatotoxicity: elevated liver enzymes or jaundice.

Before prescribing Panotile Cipro, clinicians should evaluate patient history and potential risk factors.

• Tendon disorders: avoid use in patients with recent tendon injury or corticosteroid therapy.
• Cardiac risk: assess QT interval in patients with known arrhythmias.
• Renal impairment: adjust dose in patients with reduced kidney function.
• Pregnancy and lactation: contraindicated unless benefits outweigh risks.
• Drug hypersensitivity: screen for known fluoroquinolone allergy.
• Store at below 25°C: keep in original container, protect from moisture and direct sunlight.

Ciprofloxacin interacts with several medicines that can alter its efficacy or increase toxicity.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: reduce ciprofloxacin absorption.
• Warfarin: may enhance anticoagulant effect and increase bleeding risk.
• Theophylline: can raise serum theophylline levels, leading to toxicity.

Moderate Interactions (Monitor Closely)

• NSAIDs (e.g., ibuprofen, naproxen): may increase risk of central nervous system stimulation.
• Diabetic agents (e.g., insulin, sulfonylureas): ciprofloxacin can affect blood glucose control.
• Corticosteroids: combined use may raise tendon‑rupture risk.